ClearSignal — Mar 13, 2026

Federal cybersecurity and surveillance oversight face mounting challenges as FBI warrantless searches surge 34% under FISA 702, while regulatory uncertainty grows around commercial spyware and telecom security following major policy reversals. Simultaneously, operational strain intensifies across defense and critical infrastructure sectors, from an $11 billion six-day Middle East operation and Arctic exercise withdrawals to sophisticated cyberattacks crippling major medical device manufacturers. These converging pressures underscore systemic vulnerabilities in both policy frameworks and operational resilience that demand executive attention.

Top 3

  1. Exclusive: New data shows increase in FBI searches of Americans’ data last year — FBI warrantless searches of Americans’ communications under FISA Section 702 jumped 34% to 7,413 cases, representing a significant expansion of domestic surveillance activities through foreign intelligence authorities. This increase arrives amid ongoing congressional debate over Section 702 reauthorization and civil liberties protections, creating immediate compliance and oversight implications for agencies handling classified intelligence. — the-record
  2. Price tag for Epic Fury tops $11 billion in first six days, Pentagon tells Congress — Operation Epic Fury has already consumed over $11 billion in just six days, with actual costs expected to climb as war-related expenses were excluded from initial Pentagon reporting to Congress. This burn rate signals potential budget reallocation pressures across DoD programs and underscores the fiscal volatility of rapid military operations in the Middle East theater. — defense-news
  3. Stryker tells SEC that timeline for recovery from cyberattack unknown — Medical device giant Stryker suffered a cyberattack causing global disruption to its Microsoft environment with no recovery timeline, exposing critical vulnerabilities in healthcare supply chain resilience. The incident demonstrates how sophisticated attacks on major manufacturers can cascade through the medical device sector, affecting hospital operations and patient care delivery nationwide. — the-record

Competitive Landscape

Policy & Regulatory

Agency & Mission Activity

← Archive